Table 6.
Treatment | Complete Remission | Partial remission | Persistent disease | ESRD |
---|---|---|---|---|
None (n = 3) | 1 | 2 | 0 | 0 |
RAS blockade alone (n = 6) | 3 | 0 | 3 | 0 |
Immunosuppression (n = 15) | 7 | 2 | 6 | 0 |
None; ESRD on presentation (n = 3) | 0 | 0 | 0 | 3 |
ESRD, end-stage renal disease; RAS, renin−angiotensin system.